Lysenkova LN - Search Results

1

A novel acyclic oligomycin A derivative formed via retro-aldol rearrangement of oligomycin A.

Lysenkova LN, Turchin KF, Korolev AM, Bykov EE, Danilenko VN, Bekker OB, Trenin AS, Elizarov SM, Dezhenkova LG, Shtil AA, Preobrazhenskaya MN. Lysenkova LN, et al. J Antibiot (Tokyo). 2012 Aug;65(8):405-11. doi: 10.1038/ja.2012.38. Epub 2012 May 23. J Antibiot (Tokyo). 2012. PMID: 22617550

2

The first examples of chemical modification of oligomycin A.

Lysenkova LN, Turchin KF, Danilenko VN, Korolev AM, Preobrazhenskaya MN. Lysenkova LN, et al. J Antibiot (Tokyo). 2010 Jan;63(1):17-22. doi: 10.1038/ja.2009.112. Epub 2009 Nov 13. J Antibiot (Tokyo). 2010. PMID: 19911026

3

Synthesis and properties of a novel brominated oligomycin A derivative.

Lysenkova LN, Turchin KF, Korolev AM, Danilenko VN, Bekker OB, Trenin AS, Shtil AA, Preobrazhenskaya MN. Lysenkova LN, et al. J Antibiot (Tokyo). 2012 Apr;65(4):223-5. doi: 10.1038/ja.2012.4. Epub 2012 Feb 8. J Antibiot (Tokyo). 2012. PMID: 22318333 No abstract available.

4

Synthesis and cytotoxicity of oligomycin A derivatives modified in the side chain.

Lysenkova LN, Turchin KF, Korolev AM, Dezhenkova LG, Bekker OB, Shtil AA, Danilenko VN, Preobrazhenskaya MN. Lysenkova LN, et al. Bioorg Med Chem. 2013 Jun 1;21(11):2918-24. doi: 10.1016/j.bmc.2013.03.081. Epub 2013 Apr 6. Bioorg Med Chem. 2013. PMID: 23623676

5

Study on retroaldol degradation products of antibiotic oligomycin A.

Lysenkova LN, Turchin KF, Korolev AM, Danilenko VN, Bekker OB, Dezhenkova LG, Shtil AA, Preobrazhenskaya MN. Lysenkova LN, et al. J Antibiot (Tokyo). 2014 Feb;67(2):153-8. doi: 10.1038/ja.2013.92. Epub 2013 Oct 2. J Antibiot (Tokyo). 2014. PMID: 24084683

6

Verification of oligomycin A structure: synthesis and biological evaluation of 33-dehydrooligomycin A.

Lysenkova LN, Saveljev OY, Grammatikova NE, Tsvetkov VB, Bekker OB, Danilenko VN, Dezhenkova LG, Bykov EE, Omelchuk OA, Korolev AM, Shchekotikhin AE. Lysenkova LN, et al. J Antibiot (Tokyo). 2017 Jul;70(8):871-877. doi: 10.1038/ja.2017.48. Epub 2017 Apr 19. J Antibiot (Tokyo). 2017. PMID: 28420869

7

Synthesis, antimicrobial and antiproliferative properties of epi-oligomycin A, the (33S)-diastereomer of oligomycin A.

Lysenkova LN, Saveljev OY, Omelchuk OA, Zatonsky GV, Korolev AM, Grammatikova NE, Bekker OB, Danilenko VN, Dezhenkova LG, Mavletova DA, Scherbakov AM, Shchekotikhin AE. Lysenkova LN, et al. Nat Prod Res. 2020 Nov;34(21):3073-3081. doi: 10.1080/14786419.2019.1608540. Epub 2019 May 10. Nat Prod Res. 2020. PMID: 31075992

8

Stereochemistries and Biological Properties of Oligomycin A Diels-Alder Adducts.

Omelchuk OA, Malyshev VI, Medvedev MG, Lysenkova LN, Belov NM, Dezhenkova LG, Grammatikova NE, Scherbakov AM, Shchekotikhin AE. Omelchuk OA, et al. Among authors: lysenkova ln. J Org Chem. 2021 Jun 18;86(12):7975-7986. doi: 10.1021/acs.joc.1c00296. Epub 2021 May 27. J Org Chem. 2021. PMID: 34043357

9

The formation of 2-hydroxy-4-hydroxymethyl-3-(indol-3-yl)-cyclopent-2-enone derivatives from ascorbigens.

Korolev AM, Yudina LN, Rozhkov II, Lysenkova LN, Lazhko EI, Luzikov YN, Preobrazhenskaya MN. Korolev AM, et al. Among authors: lysenkova ln. Carbohydr Res. 2001 Feb 28;330(4):469-77. doi: 10.1016/s0008-6215(00)00310-4. Carbohydr Res. 2001. PMID: 11269398

10

167-A, a new antibiotic produced by a mutant of an inactive wild strain of Amycolata autotrophica.

Malkina ND, Dudnik YV, Lysenkova LN, Lazhko EI, Galatenko OA, Katrukha GS. Malkina ND, et al. Among authors: lysenkova ln. J Antibiot (Tokyo). 1994 Mar;47(3):342-8. doi: 10.7164/antibiotics.47.342. J Antibiot (Tokyo). 1994. PMID: 8175487 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

22 results

Search Page